CRISPR could enable quick, reliable medical tests
You’ve heard of CRISPR as a way to edit or delete genes. Now, two leading biologists say it could also be used to detect cancer or viruses.
What it did: Jennifer Doudna’s team at the University of California, Berkeley used a CRISPR-based test to accurately detect DNA from cancer-causing strains of human papilloma virus in human cells. Meanwhile, Feng Zhang’s lab at the Broad Institute used CRISPR to find tumor DNA in blood samples from lung cancer patients, as well as Zika and dengue virus.
How it works: The researchers attached a signaling molecule to CRISPR. When the CRISPR system finds the DNA it's looking for, it cuts it up the genetic material around it and releases the signaling molecule, indicating that it’s found foreign DNA.
Why it matters: The CRISPR-based test could be used for many things, like testing people during a disease outbreak or finding mutations in patients that reveal drug resistance or cause cancer.
Deep Dive
Biotechnology

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

A new storage technique could vastly expand the number of livers available for transplant
It allows donor livers to be held for days—significantly longer than the standard now–and even treated if they are damaged.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.